/Investor DB

Johnson & Johnson Innovation – JJDC — 2023 Investments

7 investments dated 2023 · listed companies and verified rows first · show all

Rapport Therapeuticsrapportrx.cominNASDAQ: RAPPSeries A · Mar 2023 · $100M

Rapport is a biopharmaceutical company developing novel therapeutics.

BiotechHealthtechMedical Devices

Abe Ceesay(President)Cheryl GaultinDr. SevignyAbraham N. Ceesay(Chief Executive Officer)Steven Paul David Bredt(Founder)David Bredt, M.D., Ph.D.(Founder, Chief Scientific Officer)

Co-investorsARCH Venture PartnersSofinnova VenturesCapital GroupThird Rock Ventures

ONL Therapeuticsonltherapeutics.cominSeries C · Mar 2023 · $15M✓ verified

ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness.

BiotechHealthtechMedical DevicesAnn Arbor, US

David Zacks(Co-Founder and Chief Scientific Officer)inDavid Esposito(President and Chief Executive Officer)inConstance Chang(Executive Officer)John K Freshley(Executive Officer, Director)inJeffrey A Jamison(Executive Officer)in

BoardAaron Fletcher(Director)in

Co-investorsBios PartnersExSight VenturesInvest MichiganNovartis Venture FundVisionary VenturesInFocus Capital Partners, LLC+3 more

Aro Biotherapeuticsarobiotx.comin𝕏Series B · Nov 2023 · $42M

Aro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins.

BiotechHealthtechPhiladelphia, US

Karyn O'Neil(Executive Officer, Director)Susan Dillon(Founder)inMark V. Laurenzi(Executive Officer)

BoardElizabeth Anderson(Director)Bruce Peacock(Director)

Co-investorsAvego BioScience CapitalHealthCapAgent CapitalBiotechnology Value FundCowen Healthcare InvestmentsNorthpond Ventures

Astraveusastraveus.com𝕏Seed · Jun 2023 · $18M

Astraveus develops the Lakhesys Benchtop Cell Factory, a microfluidic-based bioprocessing platform for scaling cell and gene therapy manufacturing with improved quality and cost efficiency.

BiotechDeep TechMedical DevicesParis, FR

Jérémie Laurent(Chief Executive Officer)

Co-investorsAdBio partnersM Ventures

Moon Surgicalmoonsurgical.comin𝕏May 2023 · $55.4M

Moon Surgical develops the Maestro robotic surgery system, a digital surgical robotics platform used by surgeons to perform procedures.

HealthtechMedical DevicesRoboticsParis, FR

Brice Gayet(Surgeon Founder)inAnne Osdoit(Chief Executive Officer)inEric Ermenault(Chief Commercial Officer)inAnne Renevot(Chief Financial Officer)inViola Fleig(Chief Operations Officer)inDavid Noonan(Chief Technology Officer)in

Co-investorsNVIDIASofinnova PartnersAgoranovCathay HealthStar51 CapitalNVentures

Prana Thoracicpranathoracic.cominMar 2023

HealthtechHouston, US

Joanna Nathan(Executive Officer, Director)in

BoardMicheal Haimour(Director)Ed Boyle(Director)Sean Churchill(Director)

Co-investorsHouston Angel NetworkNew World AngelsTMC Venture Fund

Solenic Medicalsolenic.cominJun 2023

Solenic Medical is a medical company; this page is an investor contact form and does not describe the company's products or technology in detail.

Medical DevicesCollege Station, US

James Y Lancaster(Executive Officer, Director)in

BoardJohn Hodock(Director)Robert Calvin Goforth(Director)

Co-investorsShangBay Capital LLCSugati Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.